Research in difficult to treat asthma (DTT) to develop and test novel quality improvement tool for specialist centres in the UK and worldwide

WHAT are we trying to do:
·        Research the algorithms required to identify patients with modifiable disease factors and patients who require biological treatment
·        predict patient-specific treatment response to biologic therapies so clinicians could deasign individualised treatment plans for patients
·        Develop a fully sustainable web-based interface that features remote access for specialists to record information from consultations and patients to input clinical data from questionnaires
 
WHY are we doing this (our ultimate aim):
To develop a sustainable tool for managing patients with difficult to treat asthma
 
WHERE can this tool be used:
Specialist centres
 
WHEN are we doing this:
NOW to May 2025
 
HOW will the study impact clinical practice:
machine learning algorithms will enable data driven tools that support specialists

WHO will benefit:
Patients with chronic diseases (e.g., asthma and COPD), infectious diseases (e.g., Covid-19) and rare diseases (e.g., Pompe & Fabry)